Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
University Hospital, Caen
University of Southern California
Seagen Inc.
Genmab
Seagen Inc.
Eli Lilly and Company
Pfizer
Pfizer
Tomsk National Research Medical Center of the Russian Academy of Sciences
Rigshospitalet, Denmark
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Hoffmann-La Roche
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Akeso
Blokhin's Russian Cancer Research Center
National Cancer Institute (NCI)
University of California, Davis
Eisai Inc.
Eisai Inc.
Erasca, Inc.
Incyte Corporation
City of Hope Medical Center
Seagen Inc.
Shanghai Jiao Tong University School of Medicine
Dana-Farber Cancer Institute
Sunnybrook Health Sciences Centre
AstraZeneca
Merus B.V.
SafeHeal Inc
Second Affiliated Hospital, School of Medicine, Zhejiang University
Novartis